AI-powered search
Try Polaris, our new AI-powered search!

Is there any benefit to extending the dosing interval of ixekizumab in patients with stable psoriasis?

Featuring Tina Bhutani, MD, MAS |

CEO, Synergy Dermatology  
Associate Clinical Professor of Dermatology  
University of California, SF  
San Francisco, CA

| Published October 18, 2024